1-4 of 4
Sarah A. Carratt
Close
Sort by
Journal Articles

Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R -driven myeloproliferative neoplasms

Sarah A. Carratt, Garth L. Kong, Brittany M. Curtiss, Zachary Schonrock, Lauren Maloney, Breanna N. Maniaci, Hunter Z. Blaylock, Adrian Baris, Brian J. Druker, Theodore P. Braun, Julia E. Maxson
Journal: Blood
Blood (2022) 140 (6): 644–658.
https://doi.org/10.1182/blood.2021014777
Published: 2022
Includes: Supplemental data
Journal Articles

Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling

Sarah A Carratt, PhD BS, Theodore P. Braun, MDPhD, Zachary Schonrock, BS, Brittany M. Smith, Daniel J Coleman, PhD, Garth Kong, MS, Joseph Estabrook, MS, Adrian Baris, Lauren Maloney, Julia E. Maxson, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 51–52.
https://doi.org/10.1182/blood-2020-143072
Published: 2020
Journal Articles

Myeloid-Lineage Enhancers Drive Oncogene Synergy and Represent a Novel Therapeutic Target in CSF3R-CEBPA Mutant AML

Theodore Braun, MD PhD, Cody Coblentz, Sarah A Carratt, PhD BS, Mariam Okhovat, PhD, Amy Foley, MEng., Zachary Schonrock, BS, Kimberly Nevonen, Rhonda E. Ries, MA, Shannon K. McWeeney, PhD, Claus Nerlov, PhD, Soheil Meshinchi, MD PhD, Lucia Carbone, PhD, Brian J. Druker, Julia E. Maxson, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 543.
https://doi.org/10.1182/blood-2019-124773
Published: 2019
Journal Articles

SETBP1 Mutations Accelerate NRAS-Mutant Leukemia

Sarah A Carratt, PhD BS, Zachary Schonrock, BS, Theodore Braun, MD PhD, Cody Coblentz, Amy Foley, MEng., Julia E. Maxson, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1254.
https://doi.org/10.1182/blood-2019-125125
Published: 2019